BIOREM Inc.
BRM.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -89.85% | -92.87% | 328.47% | 456.81% | 161.91% |
| Total Depreciation and Amortization | 71.61% | -30.89% | 271.98% | 33.74% | -10.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -61.03% | -193.68% | 274.65% | 364.39% | 287.83% |
| Change in Net Operating Assets | 16.62% | 55.61% | -106.85% | 18.68% | 129.80% |
| Cash from Operations | 5.57% | -4,380.85% | 18.67% | 40.08% | 320.59% |
| Capital Expenditure | 76.49% | -104.17% | 100.00% | 99.00% | -433.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 76.49% | -104.17% | 100.00% | 99.00% | -433.27% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 9.49% | -32.79% | 79.06% | -2.78% | -32.23% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.98% | 127.20% | 85.06% | -951.37% | -397.36% |
| Foreign Exchange rate Adjustments | -143.60% | -150.53% | 337.36% | -79.04% | 127.70% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.16% | -2,095.08% | 315.52% | 36.94% | 293.29% |